JAMA Cardiology – The Latest in Cardiovascular Medicine
Explore the latest advances in PCI and device therapy, treatment of myocardial infarction, dyslipidemia, heart failure, afib & rhythm disorders, TAVR, and more.
Related Articles
Aircraft Noise Exposure Linked to ‘Thicker, Weaker, and Stiffer Hearts’
UK participants who lived by airports or under a flight path had worse cardiac remodeling on CMR than those living elsewhere.
Epigenetic Regulation of Innate and Adaptive Immune Cells in Salt-Sensitive Hypertension | Circulation Research
Access to excess dietary sodium has heightened the risk of cardiovascular diseases, particularly affecting individuals with salt sensitivity of blood pressure. Our research indicates that…
3D-Echokardiographie Community trifft sich in Berlin – DHZB Akademie
Zum 3. Mal haben sich mehr als 150 Echokardiographeure aus vielen Teilen der Welt zum 3D-Workshop in Berlin getroffen.
ACC Features Participating Hospitals in US News and World Report Best Hospitals Issue
In the 2024 U.S. News & World Report “Best Hospitals” guidebook, the ACC recognizes the more than 2,000 hospitals, health systems and centers participating in…
Familial hypercholesterolaemia: how to further improve outcomes
This editorial refers to ‘Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years’, by J. R
Prevalence of Popular Smoking Cessation Aids and Associations With Quit Success
This survey study estimates the prevalences and effectiveness associated with different smoking cessation aids in England.
VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction
Myocardial infarction is a leading cause of death in individuals with non-alcoholic fatty liver disease (NAFLD). The two diseases share elevated very low-density lipoproteins (VLDL)…
Systemic Postnatal Corticosteroids, Bronchopulmonary Dysplasia, and Survival Free of Cerebral Palsy
This comparative effectiveness research assesses differences in the association of systemic postnatal corticosteroids with survival free of cerebral palsy by risk of bronchopulmonary dysplasia.
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome
This case report describes a patient with Sweet syndrome whose condition improved with spesolimab after failure of high-dose corticosteroids.
Ferroptosis: A novel paradigm in the pathophysiology of MINOCA
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a clinically distinct entity characterized by myocardial infarction without significant epicardial coronary artery stenosis. This heterogeneous syndrome,…